Vitamins D, E, B and T

1 February 2017 By Jeffrey Goldfarb

The buyout firm is shopping nutritional-supplements maker Nature’s Bounty for up to $6 bln. That price would deliver a 20 pct IRR for what was a pivotal deal in 2010. Carlyle’s timing and strategic nous may have led to a higher valuation. Debt, however, provided the real muscle.

This content is for Subscribers only

To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)